Vijoice ema?

I can help, but “Vijoice ema” isn’t specific enough for me to identify what you mean.

- Did you mean Vijoice (rilzabrutinib), a BTK inhibitor in development?
- Or are you asking about EMA (European Medicines Agency) status (e.g., whether it’s been approved in Europe, or the status of an EMA application)?
- Could “Vijoice ema” be a misspelling of a different product name?

Reply with the full drug name (and what you want to know: approval/EMA decision, pricing, clinical trial results, or safety), and I’ll answer directly.